Plaque Clinical Trial
Official title:
Evaluation of Adverse Plaque Characteristics in Coronary Computed Tomography Angiography Using Combined Near Infrared Spectroscopy With Intravascular Ultrasound [CITRUS Study]
The present study is intended to assess the vulnerability of plaques seen on CCTA by means of TVC Imaging System and to make comparisons between plaques with adverse plaque characteristics and ones without adverse plaque characteristics in terms of plaque volume and lipid core contents.
This study is to be conducted in two phases - Phases 1 and 2. In Phase 1, the vulnerability
of plaques seen on CCTA will be assessed with TVC Imaging System, and the plaque volume and
lipid core contents of plaques with versus without adverse plaque characteristics will be
compared. For the purpose of this study, the study of this phase will be a cross-sectional
study in which the shapes of vulnerable plaques seen on CCTA will be compared to their
vulnerability visualized by the TVC Imaging System.
In Phase 2, the patients with multi-vessel (polyvascular) disease of those participating in
Phase 1 will be included, and the study of this phase will be a longitudinal study in which
serial TVC imaging will be performed for non-target vessels, and any differences in changes
of plaque vulnerability when treated with moderate-dose versus high-dose statin will be
comparatively analyzed. The purpose of the present study is to determine whether there are
any significant differences in changes of plaque volume and stability when treated with
high-dose versus moderate-dose statin.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02377310 -
Pd/Pa vs iFRâ„¢ in an Unselected Population Referred for Invasive Angiography
|
N/A | |
Completed |
NCT02980497 -
Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study
|
N/A | |
Not yet recruiting |
NCT03877705 -
Xylitol Chewable Tablets Versus Xylitol Chewing Gum in Geriatric Bedridden Patients
|
Early Phase 1 | |
Completed |
NCT02666508 -
Trial of Toothpaste to Reduce Plaque and Inflammation
|
N/A | |
Completed |
NCT04921371 -
Six Week Study of Experimental Mouth Rinses: Effect on Gingivitis and Plaque
|
Phase 1 | |
Completed |
NCT05138978 -
Metagenomic and Metatranscriptomic Analysis of Clinical Plaque Samples
|
Phase 2 | |
Completed |
NCT05428189 -
Efficacy of the Disclosing Plaque Agent as a Guide to Remove the Oral Biofilm in Orthodontic Patients.
|
N/A | |
Not yet recruiting |
NCT05031260 -
COMORAL® the Oral Irrigation Unit Clinical Trial
|
N/A | |
Completed |
NCT05091216 -
The Effects of Traditional Chinese Medicine Mouthwash Solutions on the Oral Health of Leprosy Patients
|
N/A | |
Active, not recruiting |
NCT03022344 -
DD2-Coronary Plaque Morphology and Plaque Progression
|
N/A | |
Completed |
NCT05121909 -
A Study of Experimental Mouthwashes
|
Phase 4 | |
Completed |
NCT06318819 -
Plaque Removal Effectiveness of a Flossing Device Compared to the Conventional Flossing in Adults
|
N/A | |
Completed |
NCT03989427 -
The Effectiveness of Brushing and Flossing Sequence on Control of Plaque and Gingival Inflammation
|
N/A | |
Completed |
NCT04407208 -
Convalescent Plasma Therapy in Patients With COVID-19
|
Phase 1 | |
Completed |
NCT05821712 -
A New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems
|
Phase 3 | |
Completed |
NCT05239351 -
Evaluating Performance and Safety of the Medical Device Jalucomplex in the Treatment of Facial and Neck Tissue Defects
|
N/A | |
Active, not recruiting |
NCT05239117 -
Evaluating the Performance and Safety of the Medical Device Plenhyage® in the Treatment of Dermal Tissue Defects
|
N/A | |
Completed |
NCT05120141 -
A Twelve Week Study of Experimental Mouth Rinses
|
Phase 4 | |
Active, not recruiting |
NCT05239130 -
Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects
|
N/A | |
Completed |
NCT05239156 -
Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue Defects
|
N/A |